Takayasu's arteritis

Current Treatment Options in Cardiovascular Medicine

Volumn 10, Issue 2, 2008, Pages 164-172

  Koening, Curry L ^a   Langford, Carol A ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; ALLOPURINOL; AMFEBUTAMONE; ANTACID AGENT; AZATHIOPRINE; CARBAMAZEPINE; COLESTYRAMINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LIVE VACCINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFCILLIN; PHENOBARBITAL; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RIFAMYCIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; UNINDEXED DRUG; WARFARIN;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADRENAL INSUFFICIENCY; ALLERGIC PNEUMONITIS; ALLERGIC REACTION; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANAPHYLAXIS; ANTIBODY PRODUCTION; AORTA ANEURYSM; AORTA ARCH SYNDROME; AORTA DISEASE; APLASTIC ANEMIA; ARTERY OCCLUSION; AUTOIMMUNE HEPATITIS; AVASCULAR NECROSIS; BLOOD PRESSURE MONITORING; BLOOD VESSEL INJURY; BONE MARROW SUPPRESSION; BYPASS SURGERY; CATARACT; CHILL; CLAUDICATION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; COUGHING; CUSHING SYNDROME; CYSTITIS; DEMYELINATING DISEASE; DIARRHEA; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG TARGETING; FEVER; GLAUCOMA; HEADACHE; HEMORRHAGIC CYSTITIS; HERPES ZOSTER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFERTILITY; INFLAMMATION; INJECTION SITE REACTION; INTERMETHOD COMPARISON; INTERSTITIAL PNEUMONIA; ISCHEMIA; LABORATORY TEST; LEUKOPENIA; LIVER CIRRHOSIS; LIVER FIBROSIS; LUPUS LIKE SYNDROME; LYMPHOMA; MALAISE; MORNING DOSAGE; MULTIPLE SCLEROSIS; NAUSEA; NEOPLASM; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE; OLIGOMENORRHEA; OSTEOPOROSIS; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PULMONARY VASCULAR DISEASE; RASH; RECOMMENDED DRUG DOSE; REMISSION; RESTENOSIS; REVIEW; SIDE EFFECT; STEVENS JOHNSON SYNDROME; STOMACH ULCER; STOMATITIS; STRIA; SYSTEMIC THERAPY; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT GAIN;

EID: 41749107156     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-008-0018-9     Document Type: Review

References (33)

1. Weyand CM, Goronzy JJ: Medium- and large-vessel vasculitis. N Engl J Med 2003, 349:160-169.
2. Hall S, Barr W, Lie JT, et al.: Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 1985, 64:89-99.
3. Kerr GS, Hallahan CW, Giordano J, et al.: Takayasu arteritis. Ann Intern Med 1994, 120:919-929.
4. Jain S, Kumari S, Ganguly NK, Sharma BK: Current status of Takayasu arteritis in India. Int J Cardiol 1996, 54(Suppl):S111-S116.
5. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, et al.: Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 1977, 93:94-103.
6. Maksimowicz-McKinnon K, Clark TM, Hoffman GS: Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007, 56:1000-1009.
7. Vanoli M, Daina E, Salvarani C, et al.: Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum 2005, 53:100-107.
8. Nakao K, Ikeda M, Kimata S, et al.: Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases. Circulation 1967, 35:1141-1155.
9. Ishikawa K, Maetani S: Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation 1994, 90:1855-1860.
10. Ueda H, Morooka S, Ito I, et al.: Clinical observation of 52 cases of aortitis syndrome. Jpn Heart J 1969, 10:277-288.
11. Tso E, Flamm SD, White RD, et al.: Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002, 46:1634-1642.
12. Hoffman GS, Ahmed AE: Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998, 66(Suppl 1):S191-S194; discussion S195.
13. Murray L, Philippi E: 2007 Red Book. Montvale, NJ: Thomson Healthcare Inc.; 2007.
14. Hoffman GS, Leavitt RY, Kerr CS, et al.: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994, 37:578-582.
15. Valsakumar AK, Valappil UC, Jorapur V, et al.: Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol 2003, 30:1793-1798.
16. Daina E, Schieppati A, Remuzzi G: Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med 1999, 130:422-426.
17. Shelhamer JH, Volkman DJ, Parrillo JE, et al.: Takayasu's arteritis and its therapy. Ann Intern Med 1985, 103:121-126.
18. Ozen S, Duzova A, Bakkatoglu A, et al.: Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr 2007, 150:72-76.
19. Hoffman CS, Merkel PA, Brasington RD, et al.: Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004, 50:2296-2304.
20. Tato F, Rieger J, Hoffmann U: Refractory Takayasu's arteritis successfully treated with the human, monoctonal anti-tumor necrosis factor antibody adalimumab. Int Angiol 2005, 24:304-307.
21. Hoffman GS: Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol 1996, 54(Suppl):S99-S102.
22. Weaver FA, Yellin AE, Campen DH, et al: Surgical procedures in the management of Takayasu's arteritis. J Vasc Surg 1990, 12:429-437; discussion 438-439.
23. Sharma S, Gupta H, Saxena A, et al.: Results of renal angioplasty in nonspecific aortoarteritis (Takayasu disease). J Vasc Interv Radiol 1998, 9:429-435.
24. Sharma BK, Jain S, Bali HK, et al.: A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 2000, 75(Suppl 1):S147-S152.
25. Liang P, Hoffman GS: Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005, 17:16-24.
26. Yao JS, Shen F, Young WL, Yang GY: Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration. Neurochem Int 2007, 50:524-530.
27. Yao JS, Chen Y, Zhai W, et al.: Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 2004, 95:364-371.
28. Lee CZ, Yao JS, Huang Y, et al.: Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab 2006, 26:1157-1164.
29. Matsuyama A, Sakai N, Ishigami M, et al.: Minocycline for the treatment of Takayasu arteritis. Ann Intern Med 2005, 143:394-395.
30. Rodriguez-Pla A, Bosch-Gil JA, Rossello-Urgell J, et al.: Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling. Circulation 2005, 112:264-269.
31. Rittner HL, Kaiser M, Brack A, et al.: Tissue-destructive macrophages in giant cell arteritis. Circ Res 1999, 84:1050-1058.
32. Matsuyama A, Sakai N, Ishigami M, et al.: Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003, 108:1469-1473.
33. Weinblatt M, Combe B, Covucci A, et al.: Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and non-biologic disease-modifying antirheumatic drugs: a one-year randomized, placebo-controlled study. Arthritis Rheum 2006, 54:2807-2816.